Latest News about HUMA
Recent news which mentions HUMA
Earnings Scheduled For March 24, 2023
March 24, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 13, 2023
From Benzinga
5 Value Stocks In The Healthcare Sector
February 13, 2023
From Benzinga
5 Value Stocks In The Healthcare Sector
December 26, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
December 14, 2022
From Benzinga
Imago BioSciences, GrafTech International And Some Other Big Stocks Moving Higher On Monday
November 21, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 16, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 15, 2022
From Benzinga
Livent, Amgen And Some Other Big Stocks Moving Lower On Monday
September 12, 2022
From Benzinga
Humacyte Earnings Perspective: Return On Invested Capital
September 09, 2022
Tickers
HUMA
From Benzinga
Earnings Scheduled For August 12, 2022
August 12, 2022
From Benzinga
From Benzinga
95 Biggest Movers From Yesterday
June 07, 2022
From Benzinga
From Benzinga
52 Stocks Moving In Monday's Mid-Day Session
June 06, 2022
From Benzinga
73 Biggest Movers From Yesterday
May 17, 2022
From Benzinga
41 Stocks Moving In Monday's Mid-Day Session
May 16, 2022
From Benzinga
Earnings Scheduled For May 13, 2022
May 13, 2022
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For March 29, 2022
March 29, 2022
From Benzinga
From Benzinga
Humacyte's Human Acellular Vessel Shows Long Term Benefit In Hemodialysis Patients
February 28, 2022
Tickers
HUMA
From Benzinga
Humacyte Posts Preclinical Data Of Small-Diameter Human Acellular Vessel In Bypass Grafting
January 28, 2022
Tickers
HUMA
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 05, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.